{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:41:15Z","timestamp":1740120075736,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12185-019-02656-4","type":"journal-article","created":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T02:19:36Z","timestamp":1558232376000},"page":"375-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transformation of follicular lymphoma to double-hit lymphoma during adjuvant chemotherapy for concurrent ovarian carcinoma"],"prefix":"10.1007","volume":"110","author":[{"given":"Taisuke","family":"Narazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisaku","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0403-0122","authenticated-orcid":false,"given":"Motoaki","family":"Shiratsuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,18]]},"reference":[{"key":"2656_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000421-200302000-00015","volume":"26","author":"CG Demandante","year":"2003","unstructured":"Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003;26:79\u201383.","journal-title":"Am J Clin Oncol"},{"key":"2656_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1015-9584(09)60216-5","volume":"26","author":"M Tamura","year":"2003","unstructured":"Tamura M, Shinagawa M, Funaki Y. Synchronous triple early cancers occurring in the stomach, colon and gallbladder. Asian J Surg. 2003;26:46\u20138.","journal-title":"Asian J Surg"},{"key":"2656_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10350-004-6619-9","volume":"46","author":"R Van Dalen","year":"2003","unstructured":"Van Dalen R, Church J, McGannon E, Fay S, Burke C, Clark B. Patterns of surgery in patients belonging to amsterdam-positive families. Dis Colon Rectum. 2003;46:617\u201320.","journal-title":"Dis Colon Rectum"},{"key":"2656_CR4","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3109\/10428194.2014.885513","volume":"55","author":"L Mozessohn","year":"2014","unstructured":"Mozessohn L, Cheung MC, Crump M, Buckstein R, Berinstein N, Imrie K, et al. Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis. Leuk Lymphoma. 2014;55:2502\u20137.","journal-title":"Leuk Lymphoma"},{"key":"2656_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"Prat J","year":"2014","unstructured":"Prat J, FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124:1\u20135.","journal-title":"Int J Gynaecol Obstet"},{"key":"2656_CR6","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-C\u00e9ligny","year":"2004","unstructured":"Solal-C\u00e9ligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258\u201365.","journal-title":"Blood"},{"key":"2656_CR7","first-page":"1358","volume":"16","author":"S Warren","year":"1932","unstructured":"Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer. 1932;16:1358\u2013414.","journal-title":"Am J Cancer."},{"key":"2656_CR8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","volume":"15","author":"P Brice","year":"1997","unstructured":"Brice P, Bastion Y, Lepage E, Brousse N, Ha\u00efoun C, Moreau P, et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d\u2019Etude des Lymphomes Folliculaires Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. J Clin Oncol. 1997;15:1110\u20137.","journal-title":"J Clin Oncol."},{"key":"2656_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1470-2045(14)70027-0","volume":"15","author":"KM Ardeshna","year":"2014","unstructured":"Ardeshna KM, Qian W, Smith P, Braganca N, Lowry L, Patrick P, et al. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomized phase 3 trial. Lancet Oncol. 2014;15:424\u201335.","journal-title":"Lancet Oncol."},{"key":"2656_CR10","first-page":"788","volume":"6","author":"X Xu","year":"2013","unstructured":"Xu X, Zhang L, Wang Y, Zhang Q, Zhang L, Sun B, et al. Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review. Int J Clin Exp Pathol. 2013;6:788\u201394.","journal-title":"Int J Clin Exp Pathol."},{"key":"2656_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-0609.2012.01787.x","volume":"89","author":"M\u00d8 Pedersen","year":"2012","unstructured":"Pedersen M\u00d8, Gang AO, Poulsen TS, Knudsen H, Lauritzen AF, Nielsen SL, et al. Double-hit BCL2\/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma\u2014a single centre\u2019s experience. Eur J Haematol. 2012;89:63\u201371.","journal-title":"Eur J Haematol"},{"key":"2656_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1179545X17692544","volume":"10","author":"AM Bischin","year":"2017","unstructured":"Bischin AM, Dorer R, Aboulafia DM. Transformation of follicular lymphoma to a high-grade B-cell lymphoma with MYC and BCL2 Translocations and Overlapping Features of Burkitt lymphoma and acute lymphoblastic leukemia: a case report and literature review. Clin Med Insights Blood Disord. 2017;10:1\u20138.","journal-title":"Clin Med Insights Blood Disord."},{"key":"2656_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2014-04-516815","volume":"125","author":"C Casulo","year":"2015","unstructured":"Casulo C, Burack WR, Friedberg JW. Transformed follicular non-Hodgkin lymphoma. Blood. 2015;125:40\u20137.","journal-title":"Blood"},{"key":"2656_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1182\/blood-2017-03-691345","volume":"130","author":"R Kridel","year":"2017","unstructured":"Kridel R, Sehn LH, Gascoyne RD. Can histologic transformation of follicular lymphoma be predicted and prevented? Blood. 2017;130:258\u201366.","journal-title":"Blood"},{"key":"2656_CR15","doi-asserted-by":"publisher","first-page":"e1002197","DOI":"10.1371\/journal.pmed.1002197","volume":"13","author":"R Kridel","year":"2016","unstructured":"Kridel R, Chan FC, Mottok A, Boyle M, Farinha P, Tan K, et al. Histological transformation and progression in follicular lymphoma: a clonal evolution study. PLoS Med. 2016;13:e1002197.","journal-title":"PLoS Med."},{"key":"2656_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","volume":"46","author":"J Okosun","year":"2014","unstructured":"Okosun J, B\u00f6d\u00f6r C, Wang J, Araf S, Yang CY, Pan C, et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet. 2014;46:176\u201381.","journal-title":"Nat Genet"},{"key":"2656_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","volume":"6","author":"L Pasqualucci","year":"2014","unstructured":"Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, et al. Genetics of follicular lymphoma transformation. Cell Rep. 2014;6:130\u201340.","journal-title":"Cell Rep."},{"key":"2656_CR18","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351:2159\u201369.","journal-title":"N Engl J Med"},{"key":"2656_CR19","first-page":"35","volume":"2","author":"PA Andrews","year":"1990","unstructured":"Andrews PA, Howell SB. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells. 1990;2:35\u201343.","journal-title":"Cancer Cells."},{"key":"2656_CR20","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/jnci\/92.14.1165","volume":"92","author":"LB Travis","year":"2000","unstructured":"Travis LB, Andersson M, Gospodarowicz M, van Leeuwen FE, Bergfeldt K, Lynch CF, et al. Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst. 2000;92:1165\u201371.","journal-title":"J Natl Cancer Inst"},{"key":"2656_CR21","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1016\/j.fct.2010.08.005","volume":"48","author":"CC Danesi","year":"2010","unstructured":"Danesi CC, Bellagamba BC, Dihl RR, de Andrade HH, Cunha KS, Lehmann M. Evaluation of the genotoxicity of cisplatin, paclitaxel and 5-fluorouracil combined treatment in the Drosophila wing-spot test. Food Chem Toxicol. 2010;48:3120\u20134.","journal-title":"Food Chem Toxicol"},{"key":"2656_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/toxsci\/kfu078","volume":"140","author":"SD Dertinger","year":"2014","unstructured":"Dertinger SD, Avlasevich SL, Torous DK, Bemis JC, Phonethepswath S, Labash C, et al. Persistence of cisplatin-induced mutagenicity in hematopoietic stem cells: implications for secondary cancer risk following chemotherapy. Toxicol Sci. 2014;140:307\u201314.","journal-title":"Toxicol Sci"},{"key":"2656_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12185-017-2226-0","volume":"106","author":"M Takagi","year":"2017","unstructured":"Takagi M. DNA damage response and hematological malignancy. Int J Hematol. 2017;106:345\u201356.","journal-title":"Int J Hematol"},{"key":"2656_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/bjc.1996.105","volume":"73","author":"TL Walker","year":"1996","unstructured":"Walker TL, White JD, Esdale WJ, Burton MA, DeCruz EE. Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression. Br J Cancer. 1996;73:610\u20134.","journal-title":"Br J Cancer"},{"key":"2656_CR25","first-page":"1121","volume":"9","author":"M Ikeguchi","year":"2002","unstructured":"Ikeguchi M, Nakamura S, Kaibara N. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment. Oncol Rep. 2002;9:1121\u20136.","journal-title":"Oncol Rep"},{"issue":"351","key":"2656_CR26","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"18","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;18(351):2159\u201369.","journal-title":"N Engl J Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02656-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02656-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:30:19Z","timestamp":1589671819000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02656-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,18]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2656"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02656-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2019,5,18]]},"assertion":[{"value":"6 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}